...
首页> 外文期刊>Pain and therapy. >Sufentanil Sublingual for Acute Post-Operative Pain: A Systematic Literature Review Focused on Pain Intensity, Adverse Events, and Patient Satisfaction
【24h】

Sufentanil Sublingual for Acute Post-Operative Pain: A Systematic Literature Review Focused on Pain Intensity, Adverse Events, and Patient Satisfaction

机译:Sufentanil舌下术后痛苦:一个系统的文献综述,重点关注疼痛强度,不良事件和患者满意度

获取原文
           

摘要

ContextPain is commonly experienced among patients after surgical procedures. Clinical pain management after surgery is far from being successful. Patients may control postoperative pain by self-administration of intravenous opioids using devices designed for this purpose (patient-controlled analgesia or PCA). PCA devices have been developed including the sufentanil sublingual tablet system (SSTS). A systematic review of the use of SSTS for postoperative pain is needed to identify an alternative method of pain management.ObjectivesTo systematically review literature to establish the efficacy and the safety of PCA with SSTS used in the treatment of moderate-to-severe acute post-operative pain in a hospital setting.MethodsEmbase, MEDLINE, Google Scholar, and Cochrane Central Trials Register were systematically searched in December 2019 for studies examining SSTS for pain in adult after surgical procedures. The methodological quality of the studies and their results were appraised using the Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) checklist and specific measurement properties criteria, respectively.ResultsSixteen studies evaluating SSTS were included for a total of 2311 patients. All participants in the SSTS group reported NRS?≤?4 within 24?h after surgery. Patient satisfaction was high, with a minimum of 70% satisfaction among patients treated with SSTS. The most common adverse events (AEs) overall for SSTS 15 and 30 mcg were nausea, vomiting, and headache. AEs observed in the studies were generally consistent with those associated with opioids and the postsurgical setting.ConclusionsSSTS is an important system for the management of moderate-to-severe acute pain in a hospital setting. SSTS is well tolerated, with no unexpected adverse events (AEs) and no clinically meaningful vital sign changes. These data confirm the safety and tolerability of the SSTS. Successful pain management resulted in a high level of acceptance of the SSTS by patients with high satisfaction for the method of pain control.
机译:外科手术后患者通常在患者中常见。手术后的临床疼痛管理远非成功。使用为此目的设计的装置(患者控制镇痛或PCA),患者可以通过自我施用静脉内阿片类药物来控制术后疼痛。已经开发了PCA器件,包括Sufentanil舌下片系统(SSTS)。需要对术后疼痛使用SST的系统审查,以确定止痛态度的替代方法.Bobjectivesto系统地审查文献,以确定PCA的疗效和安全性,用于治疗中度至严重的急性急性后在医院设定的手术疼痛。2019年12月,在2019年12月进行了系统地搜查了一定程度地检测了Medlinsembase,Medline,Google Scholar和Cochrane Central试验登记册,用于研究外科手术后成人疼痛的研究。研究的方法论质量及其结果是使用基于共识的卫生测量仪器(COSMIN)清单和具体测量性质标准的基于共识的标准进行评估。评估SSTS的研究总计2311名患者。 SSTS组中的所有参与者报告了NRS?≤α4在手术后24?H内。患者满意度很高,患有SST的患者至少具有70%的满意度。 SST 15和30 McG总体上总体的不良事件(AES)是恶心,呕吐和头痛。在研究中观察到的AES通常与与阿片类药物相关的AES和后勤凝视。结论是在医院环境中管理中度至严重急性疼痛的重要系统。 SSTS耐受良好,没有意外的不良事件(AES),没有临床有意义的生命符号变化。这些数据确认了SST的安全性和可容忍性。成功的疼痛管理由患者对SST的高度接受,对疼痛控制的方法高满意。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号